Examiner: ABBAS, SYED JARAR

Tech Center 1600 • Art Units: 1618 1645 1656 1674

This examiner grants 0% of resolved cases

Performance Statistics

0.0%

Allow Rate

-60.0% vs TC avg

Total Applications

+0.0%

Interview Lift

1196

Avg Prosecution Days

Based on 2 resolved cases, 2023–2026

2.6%

§101 Eligibility

27.0%

§102 Novelty

17.4%

§103 Obviousness

35.7%

§112 Clarity

App #	Title	Status	Assignee
19371802	Methods of Treating Red Blood Cell Disorders	Non-Final OA	Dana-Farber Cancer Institute, Inc.
18303421	IL-17 RECEPTOR MODULATOR SCREENING SYSTEM	Non-Final OA	New York University
17689117	METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY	Non-Final OA	The General Hospital Corporation
17778593	METHOD FOR DETECTING CANCER BONE METASTASIS AND DETECTION REAGENT	Non-Final OA	TOSOH CORPORATION

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.